ZimVie Inc (ZIMV)
16.72
-0.70
(-4.02%)
USD |
NASDAQ |
May 23, 16:00
16.72
0.00 (0.00%)
After-Hours: 20:00
ZimVie Enterprise Value: 940.91M for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 22, 2024 | 940.91M |
May 21, 2024 | 937.09M |
May 20, 2024 | 930.27M |
May 17, 2024 | 929.99M |
May 16, 2024 | 928.90M |
May 15, 2024 | 920.72M |
May 14, 2024 | 920.72M |
May 13, 2024 | 924.54M |
May 10, 2024 | 919.90M |
May 09, 2024 | 928.63M |
May 08, 2024 | 885.24M |
May 07, 2024 | 903.52M |
May 06, 2024 | 897.25M |
May 03, 2024 | 896.70M |
May 02, 2024 | 897.27M |
May 01, 2024 | 888.27M |
April 30, 2024 | 880.09M |
April 29, 2024 | 892.91M |
April 26, 2024 | 897.00M |
April 25, 2024 | 887.73M |
April 24, 2024 | 896.73M |
April 23, 2024 | 903.27M |
April 22, 2024 | 888.00M |
April 19, 2024 | 886.36M |
April 18, 2024 | 893.18M |
Date | Value |
---|---|
April 17, 2024 | 883.64M |
April 16, 2024 | 893.45M |
April 15, 2024 | 894.82M |
April 12, 2024 | 899.18M |
April 11, 2024 | 927.55M |
April 10, 2024 | 930.27M |
April 09, 2024 | 928.91M |
April 08, 2024 | 925.64M |
April 05, 2024 | 924.27M |
April 04, 2024 | 927.00M |
April 03, 2024 | 940.09M |
April 02, 2024 | 938.73M |
April 01, 2024 | 969.27M |
March 31, 2024 | 915.27M |
March 28, 2024 | 886.16M |
March 27, 2024 | 881.26M |
March 26, 2024 | 870.64M |
March 25, 2024 | 873.09M |
March 22, 2024 | 885.34M |
March 21, 2024 | 883.98M |
March 20, 2024 | 896.50M |
March 19, 2024 | 886.70M |
March 18, 2024 | 887.25M |
March 15, 2024 | 883.36M |
March 14, 2024 | 879.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
486.07M
Minimum
Mar 07 2022
1.182B
Maximum
Apr 19 2022
789.35M
Average
753.99M
Median
Jun 30 2023
Enterprise Value Benchmarks
Orthofix Medical Inc | 638.03M |
Stryker Corp | 138.24B |
Globus Medical Inc | 9.059B |
Paragon 28 Inc | 705.09M |
Perspective Therapeutics Inc | 748.78M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -7.761M |
Revenue (Quarterly) | 118.20M |
Total Expenses (Quarterly) | 117.31M |
EPS Diluted (Quarterly) | -0.29 |
Gross Profit Margin (Quarterly) | 62.56% |
Profit Margin (Quarterly) | -6.57% |
Earnings Yield | -83.91% |
Normalized Earnings Yield | -5.659 |